NATIONAL HEALTH INVESTORS (NHI) director awarded 1,268 restricted stock shares

Rhea-AI Filing Summary

National Health Investors director receives stock grant

NATIONAL HEALTH INVESTORS INC reported that director Robert A. McCabe Jr. acquired 1,268 shares of common stock as a restricted stock award on March 3, 2026. The grant was made at no cash cost and increases his direct holdings to 43,268.96 shares.

The restricted stock vests in full on March 3, 2027, provided he continues serving as a director through that date. Until vesting, these shares typically remain subject to forfeiture conditions tied to his board service.

Insider Trade Summary

Net Buyer: 1,268 shares

Net Buy 1 txn

Insider MCCABE ROBERT A JR

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Shares Of Common Stock	1,268	$0.00	$0.00

Holdings After Transaction: Shares Of Common Stock — 43,268.96 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of restricted stock awarded on March 3, 2026, which vests in full on March 3, 2027, subject to the reporting person's continued service as a director through such date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/05/2026 - 05:15 PM Learn about SEC filing dates

FAQ

What insider transaction did NHI director Robert A. McCabe Jr. report?

Robert A. McCabe Jr., a director of NATIONAL HEALTH INVESTORS INC (NHI), reported receiving a grant of 1,268 shares of common stock as restricted stock. This equity award increased his direct holdings to 43,268.96 shares following the transaction.

When does the new restricted stock grant for NHI director McCabe vest?

The restricted stock granted to Robert A. McCabe Jr. on March 3, 2026 vests in full on March 3, 2027. Vesting is conditioned on his continued service as a director through that date, meaning the shares remain at risk of forfeiture until then.

Did NHI director McCabe buy shares on the open market in this Form 4?

No, the Form 4 shows a grant or award acquisition, not an open-market purchase. McCabe received 1,268 restricted shares at a reported price of $0.00 per share, reflecting an equity compensation award rather than a cash investment transaction.

How many NHI shares does Robert A. McCabe Jr. own after this award?

After the March 3, 2026 restricted stock grant, director Robert A. McCabe Jr. is reported to directly own 43,268.96 shares of NATIONAL HEALTH INVESTORS INC common stock. This total includes the newly awarded 1,268 restricted shares subject to vesting conditions.

What does transaction code "A" mean in the NHI Form 4 filing?

Transaction code "A" in this NHI Form 4 indicates a grant, award, or other acquisition of securities. Here, it reflects a director equity compensation grant of 1,268 restricted shares, rather than a traditional market purchase or sale of the company’s stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCCABE ROBERT A JR

(Last) (First) (Middle)

500 CHURCH STREET

SUITE 200

(Street)

NASHVILLE TN 37219

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Shares Of Common Stock	03/03/2026		A		1,268(1)	A	$0	43,268.96	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock awarded on March 3, 2026, which vests in full on March 3, 2027, subject to the reporting person's continued service as a director through such date.

	/s/ Kimberly V. Ouimet, by limited power of attorney	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.